5Rajan DK,Soulen MC,Clark TW,et al.Sarcomas metastatic to the liver:response and survival after cisplatin,doxorubicin,mitomycin-C,Ethiodol,and polyvinyl alcohol chemoembolization[J].J Vasc Interv Radiol,2001,12(2):187-193. 被引量：1
6Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J].Science,1998,279(5350):577-580. 被引量：1
7Heinrich MC,Griffth DJ,Druker,et al.Inhibitor of c-kit receptor tyrosine kinase activity by STI-571,a selective tyrosine kinase inhibitor[J].Blood,2000,96(3):925-932. 被引量：1
8Tuveson DA,Willis NA,Jacks T,et al.STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein:Biological and clinical implications[J].Oncogene,2001,20(36):5054-5058. 被引量：1
9Joensuu H,Roberts PJ,Sarlomo-Rikala M,et al.Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor[J].N Engl J Med,2001,344(14):1052-1056. 被引量：1
10George D,Demetri MD,Margaret von Meherm MD,et al.Efficacy and safety of Imatinib Mesylate in advanced gastrointestinal stromal tumors[J].N Engl J Med,2002,347(7):472-480. 被引量：1
二级参考文献16
1JOENSUU H;Fletcher C;Dimitrijevic S.Management of malignant gastrointestinal stromal tumours[J],2002. 被引量：1
2DeMatteo RP;Heinrich MC;El-Rifai WM.Clinical management of gastrointestinal stromal tumors:before and after STI-571[J],2002. 被引量：1
3Sakurai S;Fukasawa T;Chong JM.Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal[J],1999. 被引量：1
4Sarlomo-Rikala M;Kovatich AJ;Barusevicius A.CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34,1998. 被引量：1
5Sircar K;Hewlett BR;Huizinga JD.Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors[J],1999. 被引量：1
7Tuveson DA;Willis NA;Jacks T.STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications[J],2001(36). 被引量：1
8Van Oosterom AT;Judson I;Verweij J.Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study[J],2001. 被引量：1
9Benjamin RS;Rankin C;Fletcher C.Phase Ⅲ dose-randomized study of imatini Mesylate (STI571) for GIST: intergroup S0033 early results (abstract 3271),2003. 被引量：1
10VERWEIJ J;Casali PG;Zalcberg J.Early efficacy comparison of two doses of imatini for the treatment of advanced gastro-intestinal stromal tumoars(GIST): interm results of a randomized phase Ⅲ trial from the EORTC-STBSG,ISG and AGITG (abstract 3272),2003. 被引量：1
